Prosecution Insights
Last updated: October 04, 2026

Viridant Ip

Technology areas: Chemistry & Materials • Semiconductors, Circuits & Optics • Medical Devices & Mechanical Engineering

7 pending office actions • 5 clients • 6 examiners • 6 art units • 0 of 7 (0%) have an AI response strategy ready • 4 patents granted in the last 365 days

Analysis

Viridant IP focuses on Biotechnology & Pharmaceuticals, managing 65 career applications. The firm has a resolved allowance rate pct of 95.0. This rate indicates success in securing patent grants for its clients in the Biotechnology & Pharmaceuticals sector. Practitioners can use the 65 career applications to evaluate the firm's historical outcomes. These metrics offer a basis for setting expectations for future filings in this technical field. The 95.0 resolved allowance rate pct provides a measure of success for applications managed by the firm.

Currently, the firm has 7 pending office actions. Its avg office actions per allowance is 4.16. This 4.16 avg office actions per allowance reflects the number of examiner interactions typically required to reach an allowance. With 7 pending office actions, the firm continues to manage its active cases. The 4.16 avg office actions per allowance helps practitioners estimate the resources needed for the examination phase. The 95.0 resolved allowance rate pct and the 7 pending office actions provide a view of the firm's performance.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Quality Metrics (n=65 apps, methodology: how we score firms)

95.0%
Allowance Rate
n=65
+0.80σ
Allowance Rate (norm)
n=65
4.2
OAs to Allowance
n=38
+0.37σ
OAs to Allow (norm)
n=38
1027 days
Time to Allowance
n=38
+8.0pp
Interview Lift
n=65
35.0%
RCE Rate
n=65
2.9%
Appeal Rate
n=65

Rejection Performance (% of received rejections ultimately overcome)

—
§101 Overcome
n=2 (min 20)
—
§102 Overcome
n=14 (min 20)
72.4%
§103 Overcome
n=29
75.0%
§112 Overcome
n=32

Specialization & Scale

A61K, C07K, A61P
Top CPC Subclasses
20%
Top-3 CPC Share
n=65
1
Practitioners
n=65
65.0
Apps / Practitioner
n=65

Portfolio Summary

7
Total Pending OAs
3
Non-Final OAs
4
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

1
Overdue
0
Due this week
0
Due this month
0
Due in next 60 days
0
Due later

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

3
Hard (43%)
2
Medium (29%)
2
Easy (29%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§102 only1 (14%)
§112 only2 (29%)
Double-patenting + other1 (14%)
Multi-statute (no §101)3 (43%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

3
Life Sciences
43% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
2
Semiconductors
29% of docket
2
Mechanical / Eng
29% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

70 h
Manual time on pending OAs
14 h
Time saved (low, 20%)
24 h
Time saved (mid, 35%)
0.6 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
MENGESHA, WEBESHET 2 47.2% +12.7%
WALTERS JR, ROBERT S 1 51.5% +50.4%
MILAKOVICH, NATHAN J 1 78.1% +18.9%
KUVAYSKAYA, ANASTASIA ALEKSEYEVNA 1 72.3% +36.1%
JAGAN, MIRELLYS 1 82.9% +5.7%
PUTTLITZ, KARL J 1 69.1% +18.6%

Quick Wins (1)

Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
18572734 APPARATUS AND METHOD FOR NON-INVASIVELY SENSING INTERNAL TEMPERATURE OF A FLUID CONTAINED IN A HOUSING JAGAN, MIRELLYS —

Hard Cases (3)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 3 ordered by deadline are shown.

App #TitleExaminerDue in
18926107 SYSTEM AND APPARATUS FOR LIQUEFACTION OF NATURAL GAS MENGESHA, WEBESHET 72d overdue
19020881 APPARATUS AND SYSTEMS FOR LIQUEFACTION OF NATURAL GAS MENGESHA, WEBESHET —
18573884 IMPROVED POZZOLAN AND METHODS OF MAKING AND USING SAME KUVAYSKAYA, ANASTASIA ALEKSEYEVNA —

Interview Candidates (6)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 6 ordered by deadline are shown.

App #TitleExaminerDue in
18926107 SYSTEM AND APPARATUS FOR LIQUEFACTION OF NATURAL GAS MENGESHA, WEBESHET 72d overdue
19531511 SULFUR CATHODES, SULFUR CATHODE MATERIALS, AND APPARATUS AND METHODS FOR MAKING SAME WALTERS JR, ROBERT S —
19020881 APPARATUS AND SYSTEMS FOR LIQUEFACTION OF NATURAL GAS MENGESHA, WEBESHET —
18841381 METAL-DOPED ACTIVATED CARBON MILAKOVICH, NATHAN J —
18573884 IMPROVED POZZOLAN AND METHODS OF MAKING AND USING SAME KUVAYSKAYA, ANASTASIA ALEKSEYEVNA —
18286895 Applications of GHR-106 Monoclonal Antibody as a GnRH Antagonist PUTTLITZ, KARL J —

Client Portfolio (5 clients)

Top Art Units

Art UnitApps
37632
17171
28481
17311
28551
16461

Pending Office Actions

App #TitleClientExaminerArt UnitStatutesStatusDue inAIFiled
19531511 SULFUR CATHODES, SULFUR CATHODE MATERIALS, AND APPARATUS AND METHODS FOR MAKING SAME Carbonip Technologies Inc. WALTERS JR, ROBERT S 1717 §102 Non-Final OA — Pending Feb 05, 2026
19020881 APPARATUS AND SYSTEMS FOR LIQUEFACTION OF NATURAL GAS Steelhead Lng (Aslng) Ltd. MENGESHA, WEBESHET 3763 §103§112 Final Rejection — Pending Jan 14, 2025
18926107 SYSTEM AND APPARATUS FOR LIQUEFACTION OF NATURAL GAS Steelhead Lng (Aslng) Ltd. MENGESHA, WEBESHET 3763 §103§112 Final Rejection 72d overdue Pending Oct 24, 2024
18841381 METAL-DOPED ACTIVATED CARBON Carbonip Technologies Inc. MILAKOVICH, NATHAN J 2848 §112 Final Rejection — Pending Aug 25, 2024
18573884 IMPROVED POZZOLAN AND METHODS OF MAKING AND USING SAME Progressive Planet Solutions Inc. KUVAYSKAYA, ANASTASIA ALEKSEYEVNA 1731 §102§103§112 Non-Final OA — Pending Dec 22, 2023
18572734 APPARATUS AND METHOD FOR NON-INVASIVELY SENSING INTERNAL TEMPERATURE OF A FLUID CONTAINED IN A HOUSING Ifd Technologies Inc. JAGAN, MIRELLYS 2855 §112 Non-Final OA — Pending Dec 20, 2023
18286895 Applications of GHR-106 Monoclonal Antibody as a GnRH Antagonist VANCOUVER BIOTECH LTD. PUTTLITZ, KARL J 1646 §103DP Final Rejection — Pending Oct 13, 2023

Managing Viridant Ip's Patent Prosecution?

IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month